1. Gametogenesis is the process by which primordial germ cells mature into functional gametes through meiosis and cellular differentiation. In females, primordial germ cells become oogonia then enter meiosis to become primary oocytes, while in males they become gonocytes then spermatogonia.
2. Primordial germ cells form early in development and migrate to the developing gonads, inducing their formation. In the gonads, germ cells proliferate then enter gender-specific meiotic and developmental pathways.
3. Differences between male and female gametogenesis include the timing and location of meiosis. In females, oocytes arrest in prophase I until ovulation, while in males
Giving overview of human embryonic development including spermatogenesis, oogenesis, fertilization, gastrulation, cleavage, extraembryonic layers and pregnancy
Giving overview of human embryonic development including spermatogenesis, oogenesis, fertilization, gastrulation, cleavage, extraembryonic layers and pregnancy
The functional physiology of the female genital organs of domestic animals are explained in this lecture useful for students, practitioners and aspirants of examinations.
Oogenesis and follicular development Part 1 I Endocrine Physiology IHM Learnings
Oogenesis and follicular development Part 1 I Endocrine Physiology I
The slides will talk about
1. Introduction
2. Stages of follicular development
3. Primordial follicle
4. Preantral follicle (primary and secondary follicle)
5. Antral follicle
You can also watch the same topic on HM Learnings Youtube channel.
You can also follow HM Learnings on facebook, instagram and twitter for daily updates
permatogenesis and oogenesis are the processes of formation of male and female gametes. Spermatogenesis leads to the formation of sperms, whereas oogenesis helps in the formation of ova. The fertilization of sperm and ova leads to the formation of a zygote which further develops into an embryo
In this presentation oogenesis , folliculogenesis and ovulation is discussed briefly . You can find useful content for your college and school projects.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
8. • Gametes are derived from the
primordial germ cells
(PGCs) that are formed in the
epiblast during the second
week and that move to the wall
of the yolk sac.
• Gametogenesis: It refers
to the maturation of germ cells
into functional gametes. It
involves Meiosis and
Cytodififfrentiation of
the primordial germ cell.
GAMETOGENESIS
9. Stage Approximate
Age in Days
Event Cell Population
1. 1 Fertilization and First
Clevage
Oocyte to Ootid formation and Zygote
formed.
2. 2-3 Perimplantaion and
Compaction.
4-8-16 cell blastula
3. 4-5 Free Blastula hatches
from Zona
• Trophoblast
• Inner cell mass differentiationg into
Epiblast and Hypoblast
4. 6 Implantation • Syncytio and Cytotrophoblast
• Hypoblast and Epiblast further
differentiating
5a, 5b,
5c.
7-12 Implanted Previllus • Lacunae, Chorion, Amnion, Primary Yolk
Sac, extraembryonic mesoblast, Amnion
6a, 6b 16-18 Secondary Yolk Sac,
Primitive Streak
• Villi
• Secondary Yolk Sac
• Amnion
• Primordial Germ cells
• Primitive Streak formed in later half
10.
11. • The primordial germ cells are formed
very early from the epiblast (2nd
week). They are larger than most
somatic cells, and are characterized by
vesicular nuclei with well-defined
nuclear membranes.
• Primordial germ cells spend the early
stages of development within the
extraembryonic tissues (Yolk Sac)
near the end of the primitive streak. In
this situation they are away from the
inductive influences to which the
majority of the somatic cells are
subjected during early development.
• During the fourth week these cells
begin to migrate from the yolk sac
toward the developing gonads, where
they arrive by the end of the fifth
week.
PRIMORDIAL GERM CELLS
12. • When the tail fold has
formed they appear within
the endoderm and the
splanchnopleuric
mesenchyme and
epithelium of the hindgut
as well as in the adjoining
region of the wall of the
yolk sac.
• They migrate
dorsocranially in the
mesentery, by amoeboid
movements and by growth
displacement, and reach
the genital ridges.
• Primordial germ cells
proliferate both during and
after migration to the
mesonephric ridges. Cells
which do not complete this
migration degenerate.
After segregation, when
they are often termed
primary gonocytes, they
divide to form secondary
gonocytes
13. • The Urogenital System develops
from a common mesodermal
ridge (intermediate mesoderm)
along the posterior wall of the
abdominal cavity.
• Gonadal Ridges are formed by
proliferation of the epithelium
and a condensation of underlying
mesenchyme. Germ cells do not
appear in the genital ridges until
the sixth week of development.
• If the PGC fail to reach the
ridges, the gonads do not
develop. Hence the primordial
germ cells have an inductive
influence on development of the
gonad into ovary or testis.
THE GONADAL RIDGE
14. • Human PGCs proliferate by mitosis
during migration and after reaching
the Gonadal ridges (GR).
• During this journey, while undergoing
proliferation, PGCs begin extensive
nuclear reprogramming to regain
differentiation totipotency and reset
the genomic imprinting.
• Once relocated in the GRs, PGCs are
rapidly surrounded by cords of
somatic cells.
• They undergo mitosis and meiosis as
per their gender specific pattern.
GROWTH OF PRIMORDIAL
GERM CELLS (PGC)
15. • During the 6th to 8th week of female
(XX) embryonic development, the
primordial germ cells grow and begin
to differentiate into oogonia.
• Oogonia proliferate via mitosis during
the 9th to 22nd week of embryonic
development. There can be up to
600,000 oogonia by the 8th week of
development and up to 7,000,000 by
the 5th month.
• The mitotic proliferation of oogonia
lasts several weeks and overlaps the
period of their entry into meiosis (10–
11 weeks). In fact, until the fifth
month of fetal life, mitotic oogonia
and primary oocytes in different stages
of meiosis coexist
DIFFERENTIATION OF PRIMORDIAL
GERM CELLS IN FEMALES
16. • In the male, after reaching the
developing testis, PGCs are usually
termed gonocytes.
• During the first trimester, gonocytes
are mitotically active. Of relevance,
gonocytes continue to express markers
typical of pluripotent cells and despite
some morphological differences,
gonocytes are basically equivalent to
PGCs.
• During the second trimester, most but
not all gonocytes progressively lose
mitotic activity together with the
pluripotency and PGC markers. At this
time, two new types of germ cells have
been described, intermediate germ
cells still able to proliferate and mitotic
quiescent prespermatogonia.
DIFFERENTIATION OF PRIMORDIAL
GERM CELLS IN MALES
17. • The period of human PGC
proliferation in the female lasts
from the beginning of the fourth
week to about the ninth week,
when oogonia become clearly
recognizable within the fetal ovary.
• In the ovaries, oogonia continue to
proliferate mititically until the fifth
month.
• Near the time of birth, all primary
oocytes have started prophase of
meiosis I.
• In the male, if we consider the
gonocytes equivalent to PGCs,
proliferation continues probably for a
little longer period until about the end
of the first trimester (10–12 weeks)
• In the testes, intermediate germ cells
proliferate while prespermatogonia
become progressively mitotically
quiescent.
• Male baby is born with these primordial
spermatogonia and the meiosis begins
only at puberty,
Females Males
DIFFERENCE BETWEEN PGC
GROWTH IN MALES AND FEMALES
20. After their differentiation from the PGC, oogonia increase rapidly
in number, and by the fifth month of prenatal development, the total number
of germ cells in the ovary reaches its maximum, estimated at 7 million. At this
time, cell death begins, and many oogonia as well as primary oocytes become
atretic. By the seventh month, the majority of oogonia have degenerated except
for a few near the surface. All surviving primary oocytes have entered prophase
of meiosis I, and most of them are individually surrounded by a layer of flat
epithelial cells. A primary oocyte, together with its surrounding flat
epithelial cells, is known as a primordial follicle.
21. • Primary oocytes remain in prophase and do not finish
their first meiotic division before puberty is reached. They
are arrested at the Diplotene 1.
• Oocyte maturation inhibitor (OMI), a substance
secreted by follicular cells.
• The total number of primary oocytes at birth is estimated
to vary from 7 to 2 million.
• Approximately 400,000 are present by the beginning of
puberty
• 450-500 ovulated in the lifetime.
• At puberty, a pool of growing follicles is
established and continuously maintained from the supply
of primordial follicles. Each month, 15 to 20
follicles selected from this pool begin to mature,
passing through three stages:
• 1) primary or preantral;
• 2) secondary or antral (also called
vesicular or Graafian)
• 3) preovulatory.
22.
23.
24.
25. • When the secondary follicle is mature, a surge in
luteinizing hormone (LH) induces the
preovulatory growth phase. Meiosis I is completed,
resulting in formation of two daughter cells of unequal
size, each with 23 double stranded chromosomes.
• One of the cells, the secondary oocyte, receives
most of the cytoplasm.
• The other cell forms the first polar body.
• The cell then enters meiosis II but arrests in metaphase
approximately 3 hours before ovulation. Meiosis II is
completed only if the oocyte is fertilized; otherwise, the
cell degenerates approximately 24 hours after ovulation.
• The first polar body also undergoes a second division
30. • Maturation of Sperm Begins at Puberty
• Supporting cells, which are derived from the surface epithelium of the gland in the same
manner as follicular cells, become sustentacular cells, or Sertoli cells
• Shortly before puberty, the sex cords acquire a lumen and become the seminiferous
tubules. At about the same time, primordial germ cells give rise to spermatogonial stem
cells (intermediate spermatogonia)
• At regular intervals, cells emerge from this stem cell population to form type A
spermatogonia, and their production marks the initiation of spermatogenesis.
31.
32.
33. • Spermatogonia and spermatids remain embedded in deep recesses of Sertoli cells
throughout their development.
• Sertoli cells support and protect the germ cells, participate in their nutrition, and assist in
the release of mature spermatozoa.
• Spermatogenesis is regulated by luteinizing hormone (LH) production by the pituitary.
LH binds to receptors on Leydig cells and stimulates testosterone production, which in
turn binds to Sertoli cells to promote spermatogenesis.
• Follicle stimulating hormone (FSH) is also essential because its binding to Sertoli cells
stimulates testicular fluid production and synthesis of intracellular androgen receptor
proteins.
38. CHROMOSOMAL ANOMALIES
• About 50% of the conceptions end in spontaneous abortions and almost half of them
have some major chromosomal anomaly.
• Most common abnormalities are Turner’s Syndrome, Triploidies and Trisomy 16.
• Chromosomal abnormalities account for 10% of the major birth defects.
• Genetic Mutation accounts for additional 5%.
• Example of chromosomal number anomaly
• Down’s Syndrome
• Edward Syndrome
• Patau Syndrome
• Turner’s Syndrome
• Klinefelter’s Disease
• Triple X syndrome
39. OTHER CHROMOSOMAL
ANOMALIES
• Structural Anomalies
• Cri-du-chat
• Angelman Syndrome
• Pradser Willi Syndrome
• 22q11 Syndrome
• Fragile X Syndrome
• Single gene Mutation
• Congenital Malformations
• Congenital Errors of Metabolism